正常人脑和泰-萨克斯神经节苷脂的化学结构。 - Suppr

Suppr

超能文献

The chemical structure of normal human brain and Tay-Sachs gangliosides.

作者信息

SVENNERHOLM L

出版信息

Biochem Biophys Res Commun. 1962 Nov 27;9:436-41. doi: 10.1016/0006-291x(62)90030-x.

DOI:10.1016/0006-291x(62)90030-x

PMID:13979552

Abstract

摘要

相似文献

The chemical structure of normal human brain and Tay-Sachs gangliosides.

Biochem Biophys Res Commun. 1962 Nov 27;9:436-41. doi: 10.1016/0006-291x(62)90030-x.

The metabolism of Tay-Sachs ganglioside: catabolic studies with lysosomal enzymes from normal and Tay-Sachs brain tissue.

J Clin Invest. 1972 Sep;51(9):2339-45. doi: 10.1172/JCI107045.

[On a component of the mixture of brain gangliosides, which is transferred to the Tay-Sachs ganglioside under the influence of neuraminidase].

Hoppe Seylers Z Physiol Chem. 1968 Mar;349(3):288-92.

THE ISOLATION AND IDENTIFICATION OF SIX GANGLIOSIDES AND THE ACTION OF GANGLIOSIDASE OF PURIFIED GANGLIOSIDES.

Trans Am Neurol Assoc. 1963;88:112-3.

The biosynthesis of gangliosides. Labelling of rat brain gangliosides in vivo.

Biochem J. 1971 Dec;125(4):1131-7. doi: 10.1042/bj1251131.

Neuraminidases 3 and 4 regulate neuronal function by catabolizing brain gangliosides.

FASEB J. 2017 Aug;31(8):3467-3483. doi: 10.1096/fj.201601299R. Epub 2017 Apr 25.

A differential scanning calorimetry study of the interaction of gangliosides with peanut lectin, serotonin and daunomycin.

Biochim Biophys Acta. 1980 Feb 28;596(2):186-91. doi: 10.1016/0005-2736(80)90353-3.

Action of neuraminidase from Clostridium perfringens of Tay-Sachs ganglioside.

Physiol Chem Phys. 1972;4(3):224-30.

Studies on brain lipids in Tay-Sachs' disease. II. Solubility properties of gangliosides.

J Neurochem. 1963 Feb;10:65-72.

Studies on brain lipids in Tay-Sachs' disease. III. Solubility properties of gangliosides.

J Neurochem. 1963 Feb;10:65-72.

引用本文的文献

From amaurotic idiocy to biochemically defined lipid storage diseases: the first identification of GM1-Gangliosidosis.

Free Neuropathol. 2023 Aug 8;4:12. doi: 10.17879/freeneuropathology-2023-4845. eCollection 2023 Jan.

Neuronal Ganglioside and Glycosphingolipid (GSL) Metabolism and Disease : Cascades of Secondary Metabolic Errors Can Generate Complex Pathologies (in LSDs).

Adv Neurobiol. 2023;29:333-390. doi: 10.1007/978-3-031-12390-0_12.

Neuronal Ceroid Lipofuscinosis: The Multifaceted Approach to the Clinical Issues, an Overview.

Front Neurol. 2022 Mar 11;13:811686. doi: 10.3389/fneur.2022.811686. eCollection 2022.

Genetics and Therapies for GM2 Gangliosidosis.

Curr Gene Ther. 2018;18(2):68-89. doi: 10.2174/1566523218666180404162622.

Enzyme replacement therapy and beyond-in memoriam Roscoe O. Brady, M.D. (1923-2016).

J Inherit Metab Dis. 2017 May;40(3):343-356. doi: 10.1007/s10545-017-0032-8. Epub 2017 Mar 17.

Tay-Sachs disease mutations in HEXA target the α chain of hexosaminidase A to endoplasmic reticulum-associated degradation.

Mol Biol Cell. 2016 Dec 1;27(24):3813-3827. doi: 10.1091/mbc.E16-01-0012. Epub 2016 Sep 28.

Lysosomal storage diseases--the horizon expands.

Nat Rev Neurol. 2013 Oct;9(10):583-98. doi: 10.1038/nrneurol.2013.163. Epub 2013 Aug 13.

My journey into the world of sphingolipids and sphingolipidoses.

Proc Jpn Acad Ser B Phys Biol Sci. 2012;88(10):554-82. doi: 10.2183/pjab.88.554.

Characterization of inducible models of Tay-Sachs and related disease.

PLoS Genet. 2012 Sep;8(9):e1002943. doi: 10.1371/journal.pgen.1002943. Epub 2012 Sep 20.

Ganglioside biosynthesis in developing brains and apoptotic cancer cells: X. regulation of glyco-genes involved in GD3 and Sialyl-Lex/a syntheses.

Neurochem Res. 2012 Jun;37(6):1245-55. doi: 10.1007/s11064-012-0762-9. Epub 2012 Apr 10.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验